Target intelligence / Profile preview

FEV transcription factor, ETS family member (FEV)

Target
FEV
Molecular classification
Transcription factor, ETS family, Helix-turn-helix domain-containing protein
01

Overview

FEV transcription factor, ETS family member (abbreviated FEV and also known as PET-1) is a member of the ETS transcription factor family characterized by a conserved DNA-binding domain. It plays a pivotal role in the differentiation, maturation, and maintenance of serotonergic neurons in the central nervous system by initiating and regulating serotonin synthesis and related gene expression; its expression is largely restricted to the raphe nuclei in the brain. FEV also functions as a transcriptional repressor. In pathological contexts, FEV is identified as a marker for serotonin-producing cells in certain neuroendocrine tumors and it may be involved in oncogenic fusions in some sarcomas. Additionally, it serves as a conserved regulator of hematopoietic stem cell development through ERK signaling modulation. Dysregulation of FEV has been implicated in a range of disorders, including specific cancers, neuropsychiatric conditions, and other pathologies related to abnormal serotonin physiology[1][2][4][5][7].

Other names
PET-1FEV (ETS oncogene family)FEV (fifth Ewing variant)HSRNAFEV
02

Biological functions

Differentiation of serotonergic neuronsMaturation of serotonergic neuronsRegulation of serotonin (5-HT) synthesisTranscriptional repressionMaintenance of central serotonergic neuronsRegulation of hematopoietic stem cell development
03

Disease associations

CancerSoft tissue sarcomaPsychiatric disorders (including depression, anxiety, and eating disorders)Neuroendocrine tumors (as biomarker)Sudden infant death syndrome (related pathways)
04

Biomarkers

Marker of serotonin-producing cells in neuroendocrine tumorsMarker of serotonergic neuron identity

Beyond the preview

Go deeper on FEV transcription factor, ETS family member (FEV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FEV transcription factor, ETS family member (FEV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call